The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy-Reference-Cited by-同舟云学术

The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy

Published:2022-02 Issue:2 Volume:40 Page:57.e1-57.e7
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Danley Kelsey T.,Tan Alan,Catalona William J.,Leikin Robin,Helenowski Irene,Jovanovic Borko,Gurley Michael,Kuzel Timothy M.

Funder

Northwestern University Feinberg School of Medicine

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference24 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. Accessed at: July 16, 2020 https://www.nccn.org/professionals/physician_gls.

3. American urological association prostate cancer guideline update panel. Erectile function outcome reporting after clinically localized prostate cancer treatment;Burnett;J Urol,2007

4. Sildenafil citrate after radical retropubic prostatectomy;Lowentritt;J Urol,1999

5. PDE5 inhibitors – pharmacology and clinical applications 20 years after sildenafil discovery;Andersson;Br J Pharmacol,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis;European Heart Journal - Cardiovascular Pharmacotherapy;2024-07-30

2. Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database;Minerva Urology and Nephrology;2024-05

3. Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?;Journal of Urology;2024-03

4. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health;The Journal of Sexual Medicine;2023-12-26

5. Cancer Metabolism as a Therapeutic Target and Review of Interventions;Nutrients;2023-10-01